Literature DB >> 429556

Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions.

P D Lew, R Zubler, P Vaudaux, J J Farquet, F A Waldvogel, P H Lambert.   

Abstract

Heat-labile opsonic activity was measured simultaneously in serum and pleural fluid of patients with transudates, infectious exudates (with positive or negative bacterial culture) and neoplastic exudates, using two different complement-dependent phagocytic tests: the killing of Staphylococcus aureus Wood 46 variant strain (K50 opsonic titers) and the assessment of ingestion rate of endotoxin-coated paraffin particles (Oil Red 0 uptake test). K50 opsonic titers were lower in culture-positive pleural effusions as compared to culture-negative (P < 0.002) or neoplastic effusions (P < 0.002). These results were corroborated by the Oil Red 0 uptake test. The data obtained with the two assays showed a significant correlation (P < 0.001). The hemolytic activity of complement (CH50) as well as the levels of C3 breakdown product, C3d, were measured in the same sera and pleural fluid samples and in an additional group of patients with pleural effusions of the same etiology. Effusions with positive cultures showed lower CH50 values (P < 0.01) and higher C3d values (P < 0.05) when compared to culture-negative pleural fluids. Finally, evidence for immune complexes in pleural effusions and sera was looked for by determination of Clq binding activity. Levels were higher in culture-positive effusions when compared to culture-negative fluids (P = 0.005).K50 opsonic titers showed a positive correlation with CH50 values (P < 0.001) for all fluids tested. Similarly Clq binding activity correlated with C3d levels in effusions of infectious origin (P = 0.05). Recovery experiments using the various bacterial species isolated from culture-positive pleural effusions showed evidence of complement inactivation upon incubation with pooled sera at concentrations of 10(7)-10(8) microorganisms/ml. These results indicate that one important reason for bacterial persistence in empyema may be decreased opsonization secondary to local consumption of complement.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 429556      PMCID: PMC371956          DOI: 10.1172/JCI109306

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Relation of concentrations of bacteria and bacterial antigen in cerebrospinal fluid to prognosis in patients with bacterial meningitis.

Authors:  W E Feldman
Journal:  N Engl J Med       Date:  1977-02-24       Impact factor: 91.245

2.  EMPYEMA THORACIS: A REVIEW OF 110 CASES.

Authors:  T J YEH; D P HALL; R G ELLISON
Journal:  Am Rev Respir Dis       Date:  1963-12

3.  TWO VARIANTS OF STAPHYLOCOCCUS AUREUS WOOD 46 (NCTC 7121) DIFFERING IN RESPECT TO ALPHA TOXIN PRODUCTION.

Authors:  E KJEMS
Journal:  J Bacteriol       Date:  1963-11       Impact factor: 3.490

4.  STUDIES ON HEAT-LABILE OPSONIN IN RABBIT SERUM.

Authors:  J G HIRSCH; B STRAUSS
Journal:  J Immunol       Date:  1964-01       Impact factor: 5.422

5.  The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus.

Authors:  J A Winkelstein; J A Bocchini; G Schiffman
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

6.  Chemotactic factor inactivators of human granulocytes.

Authors:  J P Brozna; R M Senior; D L Kreutzer; P A Ward
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

7.  Purification of human C3 proactivator by affinity chromatography.

Authors:  M J Auderset; P H Lambert; P A Miescher
Journal:  Immunochemistry       Date:  1974-04

8.  The C3-activator system: an alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

9.  Pleural fluid complement, complement conversion, and immune complexes in immunologic and nonimmunologic diseases.

Authors:  G G Hunder; F C McDuffie; K A Huston; L R Elveback; N G Hepper
Journal:  J Lab Clin Med       Date:  1977-12

10.  Consumptive opsoninopathy: possible pathogenesis in lethal and opportunistic infections.

Authors:  J W Alexander; M A McClellan; C K Ogle; J D Ogle
Journal:  Ann Surg       Date:  1976-12       Impact factor: 12.969

View more
  11 in total

Review 1.  Modulation of phagocytic cell function.

Authors:  P A Henricks; J Verhoef; F P Nijkamp
Journal:  Vet Res Commun       Date:  1986-05       Impact factor: 2.459

2.  Demonstration of a local exhaustion of complement components and of an enzymatic degradation of immunoglobulins in pleural empyema: a possible factor favouring the persistence of local bacterial infections.

Authors:  D P Lew; J P Despont; L H Perrin; M T Aguado; P H Lambert; F A Waldvogel
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

3.  Pharmacokinetics and therapeutic efficacy of gentamicin in an experimental pleural empyema rabbit model.

Authors:  I Shohet; A Yellin; J Meyerovitch; E Rubinstein
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

4.  Attachment of Staphylococcus aureus to polymethylmethacrylate increases its resistance to phagocytosis in foreign body infection.

Authors:  P E Vaudaux; G Zulian; E Huggler; F A Waldvogel
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

5.  Group A streptococcal peptidoglycan-polysaccharide inhibits phagocytic activity of human polymorphonuclear leukocytes.

Authors:  P A Leong; M S Cohen
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

6.  Gentamicin antibacterial activity in the presence of human polymorphonuclear leukocytes.

Authors:  P Vaudaux; F A Waldvogel
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

7.  Protease-antiprotease levels and whole-blood chemiluminescence in acute peritonitis.

Authors:  M Bergenfeldt; K Ohlsson
Journal:  Gastroenterol Jpn       Date:  1993-10

8.  High levels of complement breakdown products in tuberculous pleural effusions.

Authors:  D P Lew; L H Perrin; J D Vassalli; S Suter; P H Lambert; F A Waldvogel
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

9.  The granuloma pouch: an in vivo model for pharmacokinetic and chemotherapeutic investigations. II. Microbiological characterization.

Authors:  A Dalhoff; G Frank; G Luckhaus
Journal:  Infection       Date:  1983 Jan-Feb       Impact factor: 3.553

10.  Complement activation in pneumonia.

Authors:  U Nydegger; J J Farquet; R Zubler; P H Lambert; P A Miescher
Journal:  Med Microbiol Immunol       Date:  1979       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.